Sfoglia per RIVISTA
ESMO OPEN
Collezione AO Ordine Mauriziano

  

Items : 23

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial. in ESMO open / ESMO Open. 2025 Feb;10(2):104110. doi: 10.1016/j.esmoop.2024.104110. Epub 2025 Jan 27.

2025
AO Ordine Mauriziano

Piscaglia F; Masi G; Martinelli E; Cabibbo G; Di Maio M; Gasbarrini A; Iavarone M; Antonuzzo L; Mazzaferro V; Ballestrero A; Garufi C; Bergamo F; Celsa C; Marino D; Tovoli F; Ponziani FR; Pressiani T; Astolfi C; Gazzoli GC; Ciardiello F; Daniele B; Rimassa L;

Long-term outcomes of PARP inhibitors in ovarian cancer: survival, adverse events, and post-progression insights. in ESMO open / ESMO Open. 2024 Nov;9(11):103984. doi: 10.1016/j.esmoop.2024.103984. Epub 2024 Nov 13.

2024
AO Ordine Mauriziano

Ghisoni E; Valabrega G; Marín-Jiménez JA; Tuninetti V;

Should all advanced BRCA-mutated patients in response to first-line platinum-based chemotherapy receive PARPi + bevacizumab as maintenance therapy? in ESMO open / ESMO Open. 2024 May;9(5):102983. doi: 10.1016/j.esmoop.2024.102983. Epub 2024 Apr 24.

2024
AO Ordine Mauriziano

Turinetto M; Ray-Coquard I; Gourley C;

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM). in ESMO open / ESMO Open. 2023 Jun;8(3):101215. doi: 10.1016/j.esmoop.2023.101215. Epub 2023 Apr 3.

2023
AO Ordine Mauriziano

Pedrazzoli P; Lasagna A; Cassaniti I; Piralla A; Squeri A; Bruno R; Sacchi P; Baldanti F; Di Maio M; Beretta GD; Cinieri S; Silvestris N;

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology. in ESMO open / ESMO Open. 2023 Jun;8(3):101578. doi: 10.1016/j.esmoop.2023.101578. Epub 2023 Jun 2.

2023
AO Ordine Mauriziano

Leone AG; Miceli R; Trapani D; Massagrande M; Morano F; Marsoni S; La Verde N; Berardi R; Casolino R; Lambertini M; Dalu D; Di Maio M; Beretta GD; Perrone F; Cinieri S; Pietrantonio F;

Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients. in ESMO open / ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5.

2023
AO Ordine Mauriziano

Arenare L; Porta C; Barberio D; Terzolo S; Zagonel V; Pisconti S; Del Mastro L; Pinto C; Bilancia D; Cinieri S; Rizzo M; Migliaccio G; Montesarchio V; Del Campo L; De Lorenzo F; Iannelli E; Traclò F; Gitto L; Vaccaro MC; Frontini L; Giannarelli D; Bryce J; Piccirillo MC; Jommi C; Efficace F; Riva S; Di Maio M; Gallo C; Perrone F; et alii...

Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. in ESMO open / ESMO Open. 2022 Oct;7(5):100575. doi: 10.1016/j.esmoop.2022.100575. Epub 2022 Sep 22.

2022
AO Ordine Mauriziano
AOU Novara

Cattrini C; Mennitto A; Maiello E; Altavilla A; Messina C; Roviello G; De Giorgi U; Maiorano BA; Di Maio M;

Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM). in ESMO open / ESMO Open. 2022 Oct;7(5):100567. doi: 10.1016/j.esmoop.2022.100567. Epub 2022 Aug 19.

2022
AO Ordine Mauriziano

Ciardiello D; Chiarazzo C; Famiglietti V; Damato A; Pinto C; Zampino MG; Castellano G; Gervaso L; Zaniboni A; Oneda E; Rapisardi S; Bordonaro R; Zichi C; De Vita F; Di Maio M; Parisi A; Giampieri R; Berardi R; Lavacchi D; Antonuzzo L; Tamburini E; Maiorano BA; Parrella P; Latiano TP; Normanno N; De Stefano A; Avallone A; Martini G; Napolitano S; et alii...

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies. in ESMO open / ESMO Open. 2022 Jun;7(3):100459. doi: 10.1016/j.esmoop.2022.100459. Epub 2022 May 19.

2022
AO Ordine Mauriziano

Russo A; Incorvaia L; Capoluongo E; Tagliaferri P; Gori S; Cortesi L; Genuardi M; Turchetti D; De Giorgi U; Di Maio M; Barberis M; Dessena M; Del Re M; Lapini A; Luchini C; Jereczek-Fossa BA; Sapino A; Cinieri S;

Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience. in ESMO open / ESMO Open. 2022 Jun;7(3):100506. doi: 10.1016/j.esmoop.2022.100506. Epub 2022 Jun 10.

2022
AO Ordine Mauriziano

Boccaccino A; Borelli B; Intini R; Antista M; Bensi M; Rossini D; Passardi A; Tamberi S; Giampieri R; Antonuzzo L; Noto L; Roviello G; Zichi C; Salati M; Puccini A; Noto C; Parisi A; Rihawi K; Persano M; Crespi V; Libertini M; Giordano M; Moretto R; Lonardi S; Cremolini C;

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020. in ESMO open / ESMO Open. 2022 Dec;7(6):100593. doi: 10.1016/j.esmoop.2022.100593. Epub 2022 Oct 12.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Reale ML; Perrone F; Mariniello A; Gargiulo P; Gamba T; Di Liello R; Caglio A; Bungaro M; Audisio M; Zichi C; Paratore C; Di Maio M;

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM). in ESMO open / ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16.

2022
AO Ordine Mauriziano

Pedrazzoli P; Lasagna A; Cassaniti I; Ferrari A; Bergami F; Silvestris N; Sapuppo E; Di Maio M; Cinieri S; Baldanti F;

Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement. in ESMO open / ESMO Open. 2022 Aug;7(4):100538. doi: 10.1016/j.esmoop.2022.100538. Epub 2022 Jun 23.

2022
AO Ordine Mauriziano

Beretta GD; Casolino R; Corsi DC; Perrone F; Di Maio M; Cinieri S; Gobber G; Bellani M; Petrini F; Zocchi MT; Traclò F; Zagonel V;

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406]. in ESMO open / ESMO Open. 2022 Apr;7(2):100471. doi: 10.1016/j.esmoop.2022.100471. Epub 2022 Apr 1.

2022
AO Ordine Mauriziano

Cantini L; Mentrasti G; Lo Russo G; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; La Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; et alii...

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario. in ESMO open / ESMO Open. 2022 Apr;7(2):100406. doi: 10.1016/j.esmoop.2022.100406. Epub 2022 Feb 3.

2022
AO Ordine Mauriziano

Cantini L; Mentrasti G; Russo GL; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; et alii...

Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. in ESMO open / ESMO Open. 2021 Oct;6(5):100246. doi: 10.1016/j.esmoop.2021.100246. Epub 2021 Aug 17.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Bartolomeo M; Pietrantonio F; Di Maio M; Morano F; Corallo S; Berenato R; Ratti M; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Ritorto G; Raimondi A; Fucà G; Leone AG; Lonardi S; Antoniotti C; Smiroldo V; Amatu A;

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey. in ESMO open / ESMO Open. 2021 Oct;6(5):100238. doi: 10.1016/j.esmoop.2021.100238. Epub 2021 Aug 13.

2021
AO Ordine Mauriziano
AOU Novara

Reni M; Milella M; Cascinu S; Militello AM; Valente MM; Forti L; Scartozzi M; Giommoni E; Macchini M; Tamburini E; Bencardino K; Mosconi S; Spallanzani A; Paratore C; Bernardini I; Peretti U; Penzo E; De Lorenzo S; Rodriquenz MG; Bittoni A; Garajova I; Tortora G; Rapposelli IG; Giordano G; Noventa S; Bozzarelli S; Niger M; Cavaliere A; Di Marco M; et alii...

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort. in ESMO open / ESMO Open. 2021 Feb;6(1):100032. doi: 10.1016/j.esmoop.2020.100032. Epub 2021 Jan 4.

2021
AO Ordine Mauriziano
AOU Novara

Reni M; Milella M; Cascinu S; Falconi M; Chiarazzo C; De Lorenzo S; De Braud F; Salvatore L; Melisi D; Simbolo M; Calzavara S; Carrera P; Macchini M; Gaule M; Valente MM; Orsi G; Paratore C; Forti LG; Ratti M; Avallone A; Stuppia L; Giordano G; De Vita F; Rapposelli IG; Centonze F; Rodriquenz MG; Di Marco MC; Niger M; Tortora G; et alii...

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave? in ESMO open / ESMO Open. 2021 Apr;6(2):100100. doi: 10.1016/j.esmoop.2021.100100. Epub 2021 Mar 19.

2021
ASL Asti
AO Ordine Mauriziano

Beretta GD; Cinieri S; Tucci M; Perrone F; La Verde N; Del Mastro L; Giuffrida D; De Giorgi U; Chiari R; Russo A; Di Maio M; Silvestris N;

Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion. in ESMO open / ESMO Open. 2020 Mar;5(2):e000652. doi: 10.1136/esmoopen-2019-000652.

2020
AO Ordine Mauriziano

Santini D; Berruti A; Di Maio M; Procopio G; Bracarda S; Ibrahim T; Bertoldo F;

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. in ESMO open / ESMO Open. 2020 Mar;5(2):e000759. doi: 10.1136/esmoopen-2020-000759.

2020
AO Ordine Mauriziano

Lambertini M; Toss A; Passaro A; Criscitiello C; Cremolini C; Cardone C; Loupakis F; Viscardi G; Meattini I; Dieci MV; Ferrara R; Giusti R; Di Maio M;

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM). in ESMO open / ESMO Open. 2018 Oct 21;3(6):e000389. doi: 10.1136/esmoopen-2018-000389. eCollection 2018.

2018
AO Ordine Mauriziano

Dieci MV; Massari F; Giusti R; Inno A; Lombardi G; Noto L; Passaro A; Pietrantonio F; Spada F; Valente M; Di Maio M; Torri V;

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM). in ESMO open / ESMO Open. 2016 Dec 12;1(6):e000109. doi: 10.1136/esmoopen-2016-000109. eCollection 2016.

2016
AO Ordine Mauriziano

Di Maio M; Bruzzi P; Perrone F; Torri V; Montemurro F; Tiseo M; Vasile E;